FDA’s Commissioner of Food and Drugs Receives Public Service Award

JACKSONVILLE, Fla.–(BUSINESS WIRE)–#25thAACE–Robert M. Califf, MD, the newly appointed FDA Commissioner of Food and
Drugs received the 2016 American Association of Clinical
Endocrinologists’ (AACE) Eugene T. Davidson, MD, Public Service Award.

The AACE Eugene T. Davidson, MD, Public Service Award is presented to a
health professional, organization, or individual layperson for
outstanding contributions to advancing the mission of AACE in providing
quality health care for patients with endocrine diseases and for the
betterment of public health.

As the top FDA official, Dr. Califf is responsible for strengthening
programs and policies that enable the agency to carry out its mission to
protect and promote public health.

It’s an honor to receive the Frontiers in Science Award from AACE,” said
Dr. Califf. “After a career of caring for patients with cardiovascular
and metabolic disease and multiple opportunities to conduct clinical
trials and health services research in patients with diabetes, I am
keenly aware of the suffering caused by diabetes and the need to both
develop new therapies and understand how to deploy older therapies. We
take this very seriously at FDA.”

Previously, Dr. Califf served as the FDA’s Deputy Commissioner for
Medical Products and Tobacco from February 2015 until his appointment as
commissioner in February 2016. In that capacity, he provided executive
leadership to the Center for Drug Evaluation and Research, the Center
for Biologics Evaluation and Research, the Center for Devices and
Radiological Health, and the Center for Tobacco Products. He also
oversaw the Office of Special Medical Programs and provided direction
for cross-cutting clinical, scientific, and regulatory initiatives,
including precision medicine, combination products, orphan drugs,
pediatric therapeutics, and the advisory committee system.

A nationally and internationally recognized expert in cardiovascular
medicine, health outcomes research, healthcare quality, and clinical
research, Dr. Califf has led many landmark clinical trials and is a
frequently cited author in biomedical science, with more than 1,200
publications in peer-reviewed literature.

Dr. Califf’s biography and high-resolution photo are available here: http://media.aace.com/leadership/2016-aace-award-bios/robert-m-califf-md-macc

About the American Association of Clinical
Endocrinologists (AACE)

The American Association of Clinical Endocrinologists (AACE) represents
more than 7,000 endocrinologists in the United States and abroad. AACE
is the largest association of clinical endocrinologists in the world. A
majority of AACE members are certified in endocrinology, diabetes and
metabolism and concentrate on the treatment of patients with endocrine
and metabolic disorders including diabetes, thyroid disorders,
osteoporosis, growth hormone deficiency, cholesterol disorders,
hypertension and obesity. Visit our site at www.aace.com.

About the American College of Endocrinology
(ACE)

The American College of Endocrinology (ACE) is the educational and
scientific arm of the American Association of Clinical Endocrinologists
(AACE). ACE is the leader in advancing the care and prevention of
endocrine and metabolic disorders by: providing professional education
and reliable public health information; recognizing excellence in
education, research and service; promoting clinical research and
defining the future of Clinical Endocrinology. For more information,
visit www.aace.com/college.

Contacts

American Association of Clinical Endocrinologists
Mary Green,
407-506-2960
mgreen@aace.com